Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Study Associates Higher Risks with Total Joint Arthroplasty among Patients with Hepatitis C

Catherine Kolonko  |  Issue: May 2016  |  

Catherine Kolonko is a medical writer based in Oregon.

References

  1. Issa K, Boylan MR, Naziri Q, et al. The impact of hepatitis C on short-term outcomes of total joint arthroplasty. J Bone Joint Surg Am. 2015 Dec 2;97(23):1952–1957.
  2. Javidan P, Walker RH. Take care with type C: Serious considerations in the selection of patients with hepatitis C for total joint arthroplasty: Commentary on an article by Kimona Issa, MD, et al.: ‘The Impact of Hepatitis C on Short-Term Outcomes of Total Joint Arthroplasty.’ J Bone Joint Surg Am. 2015 Dec 2;97(23):e77.

Related Articles